Shareholding disclosure

Armistice Capital LLC

Declared position

4.99%

Threshold

Crossed upwards

Timeline

Published

24.06.2022

Transaction

28.04.2022

Voting rights breakdown

Voting rights acquired4.99%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM6N00024

Beneficial owner

Armistice Capital LLC

Declared address

Armistice Capital LLC, New-York, NY

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Armistice Capital LLC

Addex Therapeutics Ltd24.06.2022TAM6N00024

Disclosure summary

Armistice Capital LLC disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 24.06.2022, at 4.99% of voting rights. Notice category: Single shareholder.

Disclosed position

4.99%

Voting rights acquired

Voting rights acquired4.99%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Armistice Capital LLC disclosed a holding in Addex Therapeutics Ltd, published on 24.06.2022.

Publication date24.06.2022

Transaction date28.04.2022

Issuing companyAddex Therapeutics Ltd

Beneficial ownerArmistice Capital LLC

Declared addressArmistice Capital LLC, New-York, NY

CategorySingle shareholder

Voting rights acquired4.99%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAM6N00024

Source: SIX Exchange Regulation · Publication date: 24.06.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open